BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Sam Altman founded his first tech company as a teenager and was running Y combinator, the world’s leading startup accelerator, by 28. As CEO of OpenAI, the 40-year-old billionaire unleashed ChatGPT, ...

Objectives To develop a sustainable and accessible educational programme on biopsychosocial female-specific topics, for young female athletes in organised sport, their parents and coaches for future ...

On the heels of positive year-end results, Sephora's executive leadership team has come to New York to hold the retailer's first global summit.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film February 2, 2026 8:00 ...